It has been confirmed that the brain of DAT patients has already suffered irreversible damage and that there is no effective treatment, so it is particularly important to detect and treat AD in the SCD and MCI phases, where the damage is relatively reversible and effective medical intervention is possible [1, 5–7]. This evidence concerns the gene SLC6A3 and Alzheimer disease.